Ask Warren

GeneOne Life Science

011000 · KOSPI · ₩011000 · 진원생명과학

₩2,670 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩2.1B₩2.6B₩2.7B₩5.1B₩6.8B₩8.5B₩11B₩8.9B
Cost of sales₩8.7B₩2.5B₩9.1B₩8.8B₩10B₩10B₩14B₩12B
Gross profit−₩6.7B₩44M−₩6.4B−₩3.8B−₩3.2B−₩1.8B−₩3.9B−₩2.7B
Operating income−₩13B−₩2.3B−₩13B−₩12B−₩10B−₩9.1B−₩9.9B−₩10B
Net income−₩17B−₩2.4B−₩40B₩3.9B−₩6.6B−₩8.8B−₩38B₩2.2B
Net income to shareholders−₩19B−₩2.4B−₩16B−₩11B−₩15B−₩8.8B−₩16B−₩11B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩124B₩131B₩119B₩126B₩127B₩144B₩151B₩138B
Current assets₩24B₩25B₩19B₩24B₩25B₩28B₩29B₩28B
Cash and equivalents₩444M₩5.3B₩1.3B₩986M₩750M₩1.2B₩1.2B₩840M
Total liabilities₩89B₩80B₩78B₩70B₩64B₩68B₩66B₩50B
Current liabilities₩62B₩54B₩54B₩48B₩43B₩44B₩43B₩29B
Borrowings₩2.1B₩1.5B₩1.9B₩8B₩4.5B₩5.3B₩3.4B₩16B
Total equity₩36B₩51B₩41B₩55B₩62B₩76B₩86B₩88B
Shareholders' equity₩36B₩51B₩41B₩55B₩62B₩76B₩86B₩88B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩5.1B−₩2.8B−₩1.8B−₩3.6B−₩7.7B−₩3.5B−₩687M−₩3.2B
Capital spending₩0₩0₩18M₩175,643₩5.2M₩0₩1.7B₩948M
Free cash flow−₩5.1B−₩2.8B−₩1.8B−₩3.6B−₩7.7B−₩3.5B−₩2.3B−₩4.2B

Consolidated where available. Amounts in won.

Also known as: GeneOne Life Science / 진원생명과학 / 011000 / KRX:011000

Source: KRX statistical information